tetracaine (Pantocaine)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Pontocaine. (tetracaine hydrochloride) Ophthalmic agent:

Indications

Contraindications

Dosage

  • 1-2 drops into the eye prior to procedure
  • spinal anesthesia: 5-20 mg of 1% solution into subarachnoid space
  • saddle block: 2-5 mg of a 1% solution dilute with an equal volume of CSF before administration
  • topical to mucous membrane: apply 2% solution as needed; total dose should not exceed 20 mg

Injection: 1% (2 mL) Ointment (ophthalmic): 0.5% (3.75 g) Solution (ophthalmic): 0.5% (1 mL), 0.2%, 0.3%, 1%

Pharmacokinetics

elimination via liver

elimination via plasma

elimination via kidney

Adverse effects

Mechanism of action

More general terms

Component of

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. 2.0 2.1 Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
  3. 3.0 3.1 Kaiser Permanente Northern California Regional Drug Formulary, 1998
  4. Deprecated Reference

Database